ARTICLE | Clinical News
Myrcludex B: Phase IIb started
April 4, 2016 7:00 AM UTC
The companies began the open-label, Russian and German Phase IIb MYR 202 trial to evaluate Myrcludex B with Viread tenofovir in about 120 patients. Hepatera in-licensed rights from MYR to develop Myr...